BIOMODEX
Company

Last deal

$15.M

Amount

Series A

Stage

08.06.2018

Date

3

all rounds

$18.7M

Total amount

General

About Company
BIOMODEX is a medical technology company that creates tissue-like anatomical twins for rehearsal of surgeries using 3D printing.

Industry

Sector :

Subsector :

Keywords :

founded date

25.01.2015

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Based in Paris and Boston, BIOMODEX uses 3D printing to create anatomically accurate twins from medical images, which provide critical tactile feedback to users and are fully integrated into both the imaging and procedural workflow. The company's technology combines biomechanical and imaging properties with fluid dynamics, resulting in a tailored end-to-end physician experience. The solution is highly portable, easy to use, and expected to reduce procedural and hospitalization costs while improving acute and chronic outcomes. BIOMODEX has successfully commercialized several products for neurovascular and structural heart applications and is rapidly expanding its product portfolio through the application of its core technologies.
Contacts

Social url